Business · 18/01/2017Updated: 10/17/2026 · 1 min read
FDA Announces Guidance for Evaluating Abuse Potential of New Drugs
Summary
The Food and Drug Administration (FDA) has released a guidance document to help pharmaceutical companies assess the potential for abuse of new drugs, particularly those affecting the central nervous system, and determine if they require control under the Controlled Substances Act (CSA)
Original source language: Federal Register — Food and Drug AdministrationOpen original release →